Cassava Sciences (SAVA) announced the appointment of Dawn Bir to its Board of Directors. Dawn Bir is a seasoned biopharmaceutical executive and board member with a track record of contributing to development and value creation for pre-commercial and commercial biotechnology and life science companies including Reata Pharmaceuticals, Geron Corporation, and Soleno Therapeutics.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SAVA:
- Cassava Sciences initiated with a Buy at Lucid Capital
- Insider Moves: Cassava, Lithium Americas, EOG, Seagate, Pure Storage
- Cassava, Celestica, Gitlab, Pure, Stag: Stock Moves
- Cassava Sciences (SAVA) Insider Trade Alert! CEO Richard Barry Buys Stock
- Cassava Sciences Releases New Corporate Presentation